Quarterly report pursuant to Section 13 or 15(d)

Commitments and Contingencies (Details Narrative)

v3.22.0.1
Commitments and Contingencies (Details Narrative) - USD ($)
 3 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Product Liability Contingency [Line Items]    
Payments to Acquire in Process Research and Development $ 120,000
Discovery Collaboration Agreements [Member] | XOMA [Member]    
Product Liability Contingency [Line Items]    
Milestone payments 3,800,000  
Research And Development Agreement [Member] | Navigo Proteins GmbH [Member] | Technology Service [Member]    
Product Liability Contingency [Line Items]    
Payments to Acquire in Process Research and Development 100,000  
Navigo [Member] | Navigo Proteins GmbH [Member] | Technology Service [Member]    
Product Liability Contingency [Line Items]    
Milestone payments $ 1,000,000.0